Occlutech AG Company Profile

13:48 EST 24th November 2017 | BioPortfolio

News Articles [2 Associated News Articles listed on BioPortfolio]

Occlutech International AB Product Pipeline Analysis, 2017 Update [Report Updated: 31082017] Prices from USD $750

SummaryOcclutech International AB Occlutech is a medical device company that develops and supplies heart implant products. The company's products include occlutech figulla flex II, sizing occlutech AS...

Global and China Heart Defect Closure Devices Market Research by Company, Type Application 20132025 [Report Updated: 21102017] Prices from USD $2000

SummaryMarket Segment as follows:By Type ASD Closure Devices VSD Closure Devices PDA Closure Devices PFO Closure Devices LAA Closure DevicesBy Application Atrial Septal Defect ASD ...

Drugs and Medications [0 Results]


PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Atrial septostomy with a predefined diameter using a novel occlutech atrial flow regulator improves symptoms and cardiac index in patients with severe pulmonary arterial hypertension.

A novel Occlutech atrial flow regulator (AFR) implantation gives an atrial septal predefined predictable fenestration.

Available transvenous occluder designs and implantation techniques.

In this article, most of the present or available in the near future left atrial appendage (LAA) occlusion devices are discussed in terms of structure of the devices and principle technique for implan...

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Heart Failure Patients

This study aims to investigate safety and efficacy of Occlutech® AFR device in patients with HFrEF (Heart failure with reduced ejection fraction) and HFpEF (Heart failure with preserved e...

Prospective, Non-randomized, Safety and Efficacy Study of a New Occluder Design for Minimally Invasive Closure of the Left Atrial Appendage (LAA) in Patients With Atrial Fibrillation

This is a prospective, non-randomized, study of the safety and efficacy of the Occlutech® LAA occluder indicated for percutaneous LAA closure in adult male or female patients with atrial...

Follow-up Registry to Monitor the Efficacy and Safety of the Occlutech PLD Device

Collect patient data and to monitor the clinical use (safety and efficacy) of the device

MitraClip® and Hemodynamic Effects of Iatrogenic Atrial Septum Defect Closure

Aim of this prospective trial is to assess the hemodynamic effects of a MitraClip procedure caused iatrogenic arterial septal defect (iASD) and the functional changes after interventional ...

More Information about "Occlutech AG" on BioPortfolio

We have published hundreds of Occlutech AG news stories on BioPortfolio along with dozens of Occlutech AG Clinical Trials and PubMed Articles about Occlutech AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Occlutech AG Companies in our database. You can also find out about relevant Occlutech AG Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record